These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
228 related articles for article (PubMed ID: 20479958)
1. Generating a generation of proteasome inhibitors: from microbial fermentation to total synthesis of salinosporamide a (marizomib) and other salinosporamides. Potts BC; Lam KS Mar Drugs; 2010 Mar; 8(4):835-80. PubMed ID: 20479958 [TBL] [Abstract][Full Text] [Related]
2. Marizomib, a potent second generation proteasome inhibitor from natural origin. Ma L; Diao A Anticancer Agents Med Chem; 2015; 15(3):298-306. PubMed ID: 25403165 [TBL] [Abstract][Full Text] [Related]
3. Antileukemic activity and mechanism of drug resistance to the marine Salinispora tropica proteasome inhibitor salinosporamide A (Marizomib). Niewerth D; Jansen G; Riethoff LF; van Meerloo J; Kale AJ; Moore BS; Assaraf YG; Anderl JL; Zweegman S; Kaspers GJ; Cloos J Mol Pharmacol; 2014 Jul; 86(1):12-9. PubMed ID: 24737138 [TBL] [Abstract][Full Text] [Related]
4. Salinosporamide natural products: Potent 20 S proteasome inhibitors as promising cancer chemotherapeutics. Gulder TA; Moore BS Angew Chem Int Ed Engl; 2010 Dec; 49(49):9346-67. PubMed ID: 20927786 [TBL] [Abstract][Full Text] [Related]
5. Salinosporamides D-J from the marine actinomycete Salinispora tropica, bromosalinosporamide, and thioester derivatives are potent inhibitors of the 20S proteasome. Reed KA; Manam RR; Mitchell SS; Xu J; Teisan S; Chao TH; Deyanat-Yazdi G; Neuteboom ST; Lam KS; Potts BC J Nat Prod; 2007 Feb; 70(2):269-76. PubMed ID: 17243724 [TBL] [Abstract][Full Text] [Related]
6. Bacterial self-resistance to the natural proteasome inhibitor salinosporamide A. Kale AJ; McGlinchey RP; Lechner A; Moore BS ACS Chem Biol; 2011 Nov; 6(11):1257-64. PubMed ID: 21882868 [TBL] [Abstract][Full Text] [Related]
7. Synthesis of salinosporamide A and its analogs as 20S proteasome inhibitors and SAR summarization. Ma Y; Qu L; Liu Z; Zhang L; Yang Z; Zhang L Curr Top Med Chem; 2011 Dec; 11(23):2906-22. PubMed ID: 21824108 [TBL] [Abstract][Full Text] [Related]
8. Marizomib (Salinosporamide A) Promotes Apoptosis in A375 and G361 Melanoma Cancer Cells. Piskorz WM; Krętowski R; Cechowska-Pasko M Mar Drugs; 2024 Jul; 22(7):. PubMed ID: 39057424 [TBL] [Abstract][Full Text] [Related]
9. Marizomib, a proteasome inhibitor for all seasons: preclinical profile and a framework for clinical trials. Potts BC; Albitar MX; Anderson KC; Baritaki S; Berkers C; Bonavida B; Chandra J; Chauhan D; Cusack JC; Fenical W; Ghobrial IM; Groll M; Jensen PR; Lam KS; Lloyd GK; McBride W; McConkey DJ; Miller CP; Neuteboom ST; Oki Y; Ovaa H; Pajonk F; Richardson PG; Roccaro AM; Sloss CM; Spear MA; Valashi E; Younes A; Palladino MA Curr Cancer Drug Targets; 2011 Mar; 11(3):254-84. PubMed ID: 21247382 [TBL] [Abstract][Full Text] [Related]
14. Marizomib activity as a single agent in malignant gliomas: ability to cross the blood-brain barrier. Di K; Lloyd GK; Abraham V; MacLaren A; Burrows FJ; Desjardins A; Trikha M; Bota DA Neuro Oncol; 2016 Jun; 18(6):840-8. PubMed ID: 26681765 [TBL] [Abstract][Full Text] [Related]
15. Total synthesis of lactacystin and salinosporamide A. Shibasaki M; Kanai M; Fukuda N Chem Asian J; 2007 Jan; 2(1):20-38. PubMed ID: 17441136 [TBL] [Abstract][Full Text] [Related]
16. Marine actinomycetes: a new source of compounds against the human malaria parasite. Prudhomme J; McDaniel E; Ponts N; Bertani S; Fenical W; Jensen P; Le Roch K PLoS One; 2008 Jun; 3(6):e2335. PubMed ID: 18523554 [TBL] [Abstract][Full Text] [Related]
17. Specific and prolonged proteasome inhibition dictates apoptosis induction by marizomib and its analogs. Miller CP; Manton CA; Hale R; Debose L; Macherla VR; Potts BC; Palladino MA; Chandra J Chem Biol Interact; 2011 Oct; 194(1):58-68. PubMed ID: 21864512 [TBL] [Abstract][Full Text] [Related]
18. Phase I Clinical Trial of Marizomib (NPI-0052) in Patients with Advanced Malignancies Including Multiple Myeloma: Study NPI-0052-102 Final Results. Harrison SJ; Mainwaring P; Price T; Millward MJ; Padrik P; Underhill CR; Cannell PK; Reich SD; Trikha M; Spencer A Clin Cancer Res; 2016 Sep; 22(18):4559-66. PubMed ID: 27117181 [TBL] [Abstract][Full Text] [Related]
19. Leaving groups prolong the duration of 20S proteasome inhibition and enhance the potency of salinosporamides. Manam RR; McArthur KA; Chao TH; Weiss J; Ali JA; Palombella VJ; Groll M; Lloyd GK; Palladino MA; Neuteboom ST; Macherla VR; Potts BC J Med Chem; 2008 Nov; 51(21):6711-24. PubMed ID: 18939815 [TBL] [Abstract][Full Text] [Related]
20. Antiprotealide is a natural product. Manam RR; Macherla VR; Tsueng G; Dring CW; Weiss J; Neuteboom ST; Lam KS; Potts BC J Nat Prod; 2009 Feb; 72(2):295-7. PubMed ID: 19133779 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]